New diabetes clinical trial: A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes

Published on: September 23, 2020 at 09:30PM
Conditions:   Diabetes Mellitus, Type 2;   Peripheral Arterial Disease
Interventions:   Drug: Semaglutide;   Drug: Placebo (semaglutide)
Sponsor:   Novo Nordisk A/S
Not yet recruiting
https://ift.tt/3kBBF12